Diuretic response in acute heart failure - An analysis from ASCEND-HF

American Heart Journal

Volumn 170, Issue 2, 2015, Pages 313-321.e4

  Ter Maaten, Jozine M ^a   Dunning, Allison M ^b   Valente, Mattia A E ^a   Damman, Kevin ^a   Ezekowitz, Justin A ^c   Califf, Robert M ^d   Starling, Randall C ^b   Van Der Meer, Peter ^a   O'Connor, Christopher M ^b   Schulte, Phillip J ^b   Testani, Jeffrey M ^e   Hernandez, Adrian F ^b   Tang, W H Wilson ^f   Voors, Adriaan A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c MAZANKOWSKI ALBERTA HEART INSTITUTE   (Canada)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; FUROSEMIDE; NESIRITIDE;

ACUTE HEART FAILURE; AGED; ARTICLE; BLOOD PRESSURE; DIABETES MELLITUS; FEMALE; HEART FAILURE; HEMOFILTRATION; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; TREATMENT RESPONSE; ULTRAFILTRATION; URINE VOLUME; ACUTE DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FOLLOW UP; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TREATMENT OUTCOME; TRENDS; UNITED STATES;

ACUTE DISEASE; AGED; DISEASE PROGRESSION; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; FUROSEMIDE; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PATIENT ADMISSION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 84939568411     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2015.05.003     Document Type: Article

References (28)

1. J.J. McMurray, S. Adamopoulos, S.D. Anker, and et al. ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
2. K.F. Adams Jr., G.C. Fonarow, C.L. Emerman, and et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE) Am Heart J 149 2005 209 216
3. M.A. Valente, A.A. Voors, K. Damman, and et al. Diuretic response in acute heart failure: clinical characteristics and prognostic significance Eur Heart J 35 2014 1284 1293
4. G.W. Neuberg, A.B. Miller, C.M. O'Connor, and et al. Prospective randomized amlodipine survival evaluation. Diuretic resistance predicts mortality in patients with advanced heart failure Am Heart J 144 2002 31 38
5. A.A. Voors, B.A. Davison, J.R. Teerlink, and et al. Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome-an analysis from RELAX-AHF Eur J Heart Fail 16 2014 1230 1240
6. J.M. Testani, M.A. Brisco, J.M. Turner, and et al. Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure Circ Heart Fail 7 2014 261 270
7. S.S. Gottlieb, A. Stebbins, A.A. Voors, and et al. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure) J Am Coll Cardiol 62 2013 1177 1183
8. T.E. Owan, H.H. Chen, R.P. Frantz, and et al. The effects of nesiritide on renal function and diuretic responsiveness in acutely decompensated heart failure patients with renal dysfunction J Card Fail 14 2008 267 275
9. H.H. Chen, K.J. Anstrom, M.M. Givertz, and et al. NHLBI Heart Failure Clinical Research Network. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial JAMA 310 2013 2533 2543
10. C.M. O'Connor, R.C. Starling, A.F. Hernandez, and et al. Effect of nesiritide in patients with acute decompensated heart failure N Engl J Med 365 2011 32 43
11. R. de Silva, H. Loh, A.S. Rigby, and et al. Epidemiology, associated factors, and prognostic outcomes of renal artery stenosis in chronic heart failure assessed by magnetic resonance angiography Am J Cardiol 100 2007 273 279
12. P. MacDowall, P.A. Kalra, D.J. O'Donoghue, and et al. Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure Lancet 352 1998 13 16
13. C.V. Bourantas, H.P. Loh, E.I. Lukaschuk, and et al. Renal artery stenosis: an innocent bystander or an independent predictor of worse outcome in patients with chronic heart failure? A magnetic resonance imaging study Eur J Heart Fail 14 2012 764 772
14. M.M. Ciccone, M. Iacoviello, L. Gesualdo, and et al. The renal arterial resistance index: a marker of renal function with an independent and incremental role in predicting heart failure progression Eur J Heart Fail 16 2014 210 216
15. H.R. Jacobson Chronic renal failure: pathophysiology Lancet 338 1991 419 423
16. H. Fujii, S. Nakamura, S. Kuroda, and et al. Relationship between renal artery stenosis and intrarenal damage in autopsy subjects with stroke Nephrol Dial Transplant 21 2006 113 119
17. K. Damman, W.H. Tang, J.M. Testani, and et al. Terminology and definition of changes renal function in heart failure Eur Heart J 35 2014 3413 3416
18. Y. Uwai, H. Saito, Y. Hashimoto, and et al. Interaction and transport of thiazide diuretics, loop diuretics, and acetazolamide via rat renal organic anion transporter rOAT1 J Pharmacol Exp Ther 295 2000 261 265
19. D.H. Sweet, K.T. Bush, and S.K. Nigam The organic anion transporter family: from physiology to ontogeny and the clinic Am J Physiol Renal Physiol 281 2001 F197 F205
20. W. Krick, N.A. Wolff, and G. Burckhardt Voltage-driven p-aminohippurate, chloride, and urate transport in porcine renal brush-border membrane vesicles Pflugers Arch 441 2000 125 132
21. A. Kazory Emergence of blood urea nitrogen as a biomarker of neurohormonal activation in heart failure Am J Cardiol 106 2010 694 700
22. B. Kaissling, S. Bachmann, and W. Kriz Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment Am J Physiol 248 1985 F374 F381
23. J.M. Ter Maaten, M.A. Valente, K. Damman, and et al. Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy Nat Rev Cardiol 12 2015 184 192
24. G.M. Keating, and K.L. Goa Nesiritide: a review of its use in acute decompensated heart failure Drugs 63 2003 47 70
25. Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF) Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial JAMA 287 2002 1531 1540
26. H.G. Riter, M.M. Redfield, J.C. Burnett, and et al. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction J Am Coll Cardiol 47 2006 2334 2335
27. R.M. Witteles, D. Kao, D. Christopherson, and et al. Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial J Am Coll Cardiol 50 2007 1835 1840
28. H.H. Chen, A. Cataliotti, J.A. Schirger, and et al. Local renal delivery of a natriuretic peptide a renal-enhancing strategy for B-type natriuretic peptide in overt experimental heart failure J Am Coll Cardiol 53 2009 1302 1308